{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Showing 1 - 5 of 5 results
Status:
Investigational
Source:
Int J Hematol. Nov 2022;116(5):754-769.: Phase 1 Human clinical trial Completed Graft vs Host Disease/therapy
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Investigational
Source:
Int J Hematol. Nov 2022;116(5):754-769.: Phase 1 Human clinical trial Completed Graft vs Host Disease/therapy
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Investigational
Source:
Int J Hematol. Nov 2022;116(5):754-769.: Phase 1 Human clinical trial Completed Graft vs Host Disease/therapy
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Investigational
Source:
Int J Hematol. Nov 2022;116(5):754-769.: Phase 1 Human clinical trial Completed Graft vs Host Disease/therapy
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Investigational
Source:
Int J Hematol. Nov 2022;116(5):754-769.: Phase 1 Human clinical trial Completed Graft vs Host Disease/therapy
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)